Home / Intelligence / News

Search

TRINITY LIFE SCIENCES PARTNERS WITH KOMODO HEALTH

With Komodo’s Healthcare Map, Trinity EvidenceFirst™ Steers Through the Complexities of Real-World Evidence Analysis to Yield High-Impact Insights Waltham, MA, Sept 15, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today announced a partnership with Komodo Health that will unlock unique, valuable insights in combination with Trinity’s EvidenceFirst. Trinity’s experts leverage EvidenceFirst, a suite of real-world evidence (RWE) offerings, to help pharma, biotech, and medtech companies navigate to strategic, data-informed decisions across an asset’s lifecycle.…

Read Now

TRINITY LIFE SCIENCES NAMED TO THE INC. 5000 LIST

Waltham, MA, August 30, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, has been included on Inc. magazine’s annual Inc. 5000 list, the most prestigious ranking of the United States’ fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment – its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on…

Read Now

Seventy-Four Percent of Pharmaceutical Marketing Executives Say Changes in Third-Party Cookie Management Will be Impactful or Very Impactful on Their Media Plans

Waltham, MA, June 16, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, is sharing findings from its latest TGaS Advisors’ brief entitled Changes in Third-Party Cookie Management and Their Effects on Pharmaceutical Brands. The paper finds that although most respondents did not have a clear understanding of the changes in third-party cookie management, 74 percent of pharma marketing executives say the changes will be impactful or very impactful on their media plans. However, less than…

Read Now

Fourth Annual Best of Benchmark Award Winners Announced

The Awards are Given for Commercial Operations Excellence within the Pharmaceutical Industry Waltham, MA MAY 6, 2021 – Trinity Life Sciences, a leader in global life science commercialization solutions, announced the winners of the TGaS Best of Benchmark (BoBs) Awards. The Awards, which are given for commercial operations excellence within the pharmaceutical industry, were presented to teams at AbbVie, Biogen, Genentech, Lundbeck, Otsuka, Pharmacyclics and Janssen Biotech, Inc. The BoBs are based on TGaS benchmarking of large, midsize, and emerging life…

Read Now

While There are Still Unknowns, Monoclonal Antibodies Can Help in the Fight Against COVID-19

Antibodies have the Potential to Effectively Target Several Stages of the Disease with Evident Benefits at a Patient Level and a Systemic Level, According to a New White Paper by Trinity Life Sciences Waltham, MA, May 3, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, is sharing findings from its latest white paper entitled “Beyond Vaccines – How Monoclonal Antibodies Can Help in the Fight Against the COVID-19 Pandemic.” The paper finds that while there are still unknowns…

Read Now

Life Science Executives Overwhelmingly Agree that Increased Gender Representation Positively Impacts Organizations

Waltham, MA, April 1, 2021 — Trinity Life Sciences, a leader in global life science commercialization solutions, is sharing findings from its latest TGaS study entitled “Commercial Executive Pipeline Development for Women in Life Sciences.” The study finds that life science executives overwhelmingly agree that increased gender representation positively impacts organizations; however, life science companies fall below benchmark as compared to gender equity best practices in other industries. Only 44 percent of life science respondents agree that their companies’ boards/executive…

Read Now

On Average, Pharma Brands Allocated 66 Percent of their Marketing Budgets to Digital in 2020

Waltham, MA, March 29, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, is sharing findings from its latest TGaS report entitled, “Omnichannel Marketing Center of Excellence Landscape.” Omnichannel Marketing is the orchestration of multiple marketing channels to provide a consistent message to customers at various points during their journey – an important function within life science companies to ensure their brand is accessible. The report finds that on average, pharma brands allocated 66 percent of…

Read Now

Uncertainty of Government Pricing Policies, Evolution of PBMs, and 340b Program Expansion Identified as Top External Challenges for Pharma Pricing & Contracting Teams This Year

Waltham, MA, March 3, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, is sharing findings from its latest TGaS annual Landscape report entitled, “2021 Trends & Considerations in Contract Management: Responding to Pricing Pressures in an Uncertain Environment.” The report, based on biopharma companies in varying stages of development, finds that uncertainty of government pricing policies, evolution of pharmacy benefit managers (PBMs) and 340B Program* expansion are the top challenges for contracting teams at biopharma…

Read Now

Top Two Challenges for Market Access Teams in 2021 are Pricing Pressures and Evidence Generation

Waltham, MA, February 24, 2021 — Trinity Life Sciences, a leader in global life sciences solutions, is sharing findings from its latest TGaS Landscape report entitled, “Market Access Trends and Consideration for 2021: A Biopharma Perspective.” The report, based on in-depth interviews with Market Access leaders from pre-commercial and commercial biopharma companies, finds that the top two challenges for market access teams in 2021 are pricing pressures and evidence generation. “Pricing pressures continue to increase for treatments that have limited…

Read Now

Ninety Percent of Large Pharma Companies Initiated Artificial Intelligence/Machine Learning Projects In 2020

WALTHAM, Mass.–(BUSINESS WIRE)–Trinity Life Sciences, a leader in global life sciences solutions, is sharing findings from its latest TGaS Landscape report entitled, “Perspectives on Use of Artificial Intelligence/Machine Learning (AIML) for Driving Commercial Performance.” The report, based on responses from 23 different biopharma companies, finds that 90 percent of large pharmaceutical companies initiated AIML projects in 2020 compared to 60 percent of emerging biopharma companies. Marketing mix, patient identification and healthcare practitioner targeting were the most frequently sited use cases…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.